Pluvicto and lutathera FY 25
Ended Awarded Last action
- Contract number
- 36C26225F0024
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $3,485,014
Award facts
- Opportunity
-
- 6505--Notice of Intent to Sole Source Pluvicto and Lutathera Special Notice · 36C26224Q1822 · Posted Sep 18, 2024
- Contract value 100% obligated
- $3,485,014.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Millburn, NJ 07041, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$591,008 | |
| Funding Only Action | -$794,618 | |
| Supplemental Agreement for work within scope | -$496,636 | |
| Original award | $5,367,277 |
About this award
Advanced Accelerator Applications USA Inc., a Novartis subsidiary headquartered in Millburn, New Jersey, has been awarded a delivery order valued at $3.49M by Veterans Integrated Service Network 22 (VISN 22) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order, issued on November 1, 2024, is for the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) and LUTATHERA (lutetium Lu 177 dotatate), specialized radiopharmaceutical products used in targeted radioligand therapy for cancer treatment, with performance completion scheduled for October 31, 2025. This award carries no small business set-aside designation and is structured as a firm fixed-price delivery order, reflecting the company's established status as a large specialized manufacturer of nuclear medicine products for federal healthcare systems.
The contract is part of Advanced Accelerator Applications USA Inc.'s broader portfolio with the Department of Veterans Affairs, which has been the predominant funding agency across multiple VISNs. The company maintains multiple blanket purchase agreements and indefinite delivery contracts totaling tens of millions of dollars across the VA system and other federal healthcare agencies, including the Defense Health Agency and National Institutes of Health. These contract vehicles enable federal medical centers to procure radiopharmaceutical products on an as-needed basis to support diagnostic imaging and therapeutic capabilities for conditions including prostate cancer and neuroendocrine tumors. The current delivery order represents a reduction and closeout action, as indicated in the contract description, consolidating procurement activity under the existing framework.
Quick answers
Who was awarded contract 36C26225F0024?
36C26225F0024 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on November 1, 2024.
How much is contract 36C26225F0024 worth?
The government has obligated $3,485,014 on 36C26225F0024.
Is contract 36C26225F0024 an order under another contract?
Yes. 36C26225F0024 is a delivery order under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26225F0024 competed?
The extent of competition for 36C26225F0024 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award